Pyxis Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$73,790,000 over the previous period. Total operating expenses were $82,196,000.
Profit Margin
| 2019 | 0 | -2.66M | |
|---|---|---|---|
| 2020 | 0 | -12.76M | |
| 2021 | 0 | -81.53M | |
| 2022 | 0 | -117.95M | |
| 2023 | 0 | -73.79M |
PYXS Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 2M | 1.83M | 1.25M | 444K | 0 |
Gross profit | -2M | -1.83M | -1.25M | -444K | 0 |
Operating exp. | |||||
Research and development | 49.58M | 86.12M | 51.05M | 9.04M | 1.22M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 82.19M | 123.48M | 69.71M | 12.89M | 2.87M |
Operating income | -82.19M | -123.48M | -69.71M | -12.89M | -2.87M |
Other income (expenses), net | 8.40M | 2.76M | -6.25M | 66K | 107K |
Income before tax | -73.79M | -120.71M | -75.97M | -12.82M | -2.77M |
Income tax expense | 0 | -2.76M | 5.56M | -66K | -107K |
Net income | -73.79M | -117.95M | -81.53M | -12.76M | -2.66M |
Earnings per share | |||||
Basic EPS | -1.85 | -3.57 | -2.53 | -0.37 | -0.07 |
Diluted EPS | -1.85 | -3.57 | -2.53 | -0.37 | -0.07 |
| Data source | Data source | Data source |